Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Chang-Bih Shie"'
Autor:
Chih-Hsueh Lin, Ping-I Hsu, Chin-Dar Tseng, Pei-Ju Chao, I-Ting Wu, Supratip Ghose, Chih-An Shih, Shen-Hao Lee, Jia-Hong Ren, Chang-Bih Shie, Tsair-Fwu Lee
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Helicobacter pylori (H. pylori) infection is the principal cause of chronic gastritis, gastric ulcers, duodenal ulcers, and gastric cancer. In clinical practice, diagnosis of H. pylori infection by a gastroenterologists’ impression of endo
Externí odkaz:
https://doaj.org/article/babe4c2399ba482daece5d1c04cb37ae
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
A standard bismuth quadruple therapy, a fluoroquinolone-containing triple (or quadruple) therapy or a proton pump inhibitor (PPI)-amoxicillin high-dose dual therapy has been recommended as a second-line treatment for Helicobacter pylori infection by
Externí odkaz:
https://doaj.org/article/ed314d67b9e446299b5541f550bba28c
Autor:
Chien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, Wei-Yi Lei, Feng-Woei Tsay, Seng-Kee Chuah, Kuan-Yang Chen, Jyh-Chin Yang, Yu-Hwa Liu, Chao-Hung Kuo, Sz-Iuan Shiu, Chang-Bih Shie, Kuan-Hua Lin, Chia-Long Lee, Ping-I Hsu
Publikováno v:
Microorganisms, Vol 12, Iss 1, p 6 (2023)
Hybrid therapy is a recommended first-line anti-H. pylori treatment option in the American College of Gastroenterology guidelines, the Bangkok Consensus Report on H. pylori management, and the Taiwan H. pylori Consensus Report. However, the cure rate
Externí odkaz:
https://doaj.org/article/50cb34ac1ad640c1a44678c120bc8839
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Current international consensuses on Helicobacter pylori eradication therapy recommend that only regimens that reliably produce eradication rates of ⩾90% should be used for empirical treatment. The Real-world Practice & Expectation of Asia-Pacific
Externí odkaz:
https://doaj.org/article/10af49d3370d4a81851dba49237fe718
Autor:
Jui-Ting Hsu, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Wen-Wei Huang, Sheng-Yeh Tang, Kun-Feng Tsai, Li-Fu Kuo, Supratip Ghose, Jui-Che Hsu, Chih-An Shih
Publikováno v:
Medicina, Vol 58, Iss 3, p 436 (2022)
Background and Objectives: Hepatitis C virus (HCV) is a major cause of liver disease worldwide. People who inject drugs (PWIDs) constitute the majority of patients with HCV infection in the United States and Central Asia. There are several obstacles
Externí odkaz:
https://doaj.org/article/568eb3bf20134da2af74dad9635d2277
Autor:
Jiunn‐Wei Wang, Ping‐I Hsu, Ming‐Hong Lin, John Kao, Feng‐Woei Tsay, I‐Ting Wu, Chang‐Bih Shie, Deng‐Chyang Wu
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:1928-1934
Autor:
Ping-I Hsu, John Y., Kuan-Yang Chen, Wei-Chen Tai, Jyh-Chin Yang, Feng-Woei Tsay, Yu-Hwa Liu, Chien-Lin Chen, Chia-Long Lee, Hong-Zen Yeh, Chao-Hung Kuo, Seng-Kee Chuah, Hsi-Chang Lee, Chang-Bih Shie, Sz-Iuan Shiu, Kao, John Y., Yoshio Yamaoka, Graham, David Y., Deng-Chyang Wu
Publikováno v:
American Journal of Gastroenterology (Lippincott Williams & Wilkins); Jul2023, Vol. 118 Issue 7, p1184-1195, 12p
Autor:
Yoen-Young, Chuah, Deng-Chyang, Wu, Seng-Kee, Chuah, Kuan-Yang, Chen, Jyh-Chin, Yang, Chia-Long, Lee, Chien-Lin, Chen, Sz-Iuan, Shiu, Chang-Bih, Shie, Chih-An, Shih, Feng-Woei, Tsay, Yu-Hwa, Liu, Ping-I, Hsu
Publikováno v:
HelicobacterREFERENCES. 27(6)
REAP-HP study (Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication) was the pioneer study investigating the expectation and preference of physicians across Asia-Pacific in H. pylori eradicati
Autor:
Jiunn-Wei, Wang, Ping-I, Hsu, Ming-Hong, Lin, John, Kao, Feng-Woei, Tsay, I-Ting, Wu, Chang-Bih, Shie, Deng-Chyang, Wu
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 37(10)
Most consensuses recommend culture-guided therapy as third-line Helicobacter pylori treatment. This study aimed to investigate the efficacies of culture-guided therapy and empirical therapy with high-dose proton pump inhibitor (PPI) in the H. pylori
Autor:
Ping-I Hsu, Chang-Bih Shie, Sheng-Yeh Tang, Seng-Kee Chuah, Kun-Feng Tsai, Jin-Shiung Cheng, Sung-Shuo Kao, Wen-Chi Chen, Nan-Jing Peng, Feng-Woei Tsay, Zhi-Fu Tseng
Publikováno v:
Journal of the Chinese Medical Association. 84:19-24
Background Low-dose aspirin is widely used in the prevention of cardiovascular diseases. However, the use of aspirin is associated with an increased risk of gastrointestinal injury. Methods Low-dose aspirin users with a history of peptic ulcers who d